Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BIT/1GILD stock hub

BIT/1GILD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/1GILDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

138.5B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/1GILD

In the news

Latest news · BIT/1GILD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13P50 15.3P75 18.4

Trailing P/E17.3

P25 14.4P50 21.2P75 24.6

ROE43.4

P25 3.1P50 8.5P75 13.3

ROIC27.7

P25 5.3P50 8.5P75 15.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/1GILD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IT
Employees	17,000
Employees Change	-600%
Employees Change Percent	-3.41
Enterprise value	EUR 148.1B
Exchange	Borsa Italiana
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US3755581036
Last refreshed	2026-05-10
Market cap	EUR 138.5B
Price	EUR 111
Price currency	EUR
Rev Per Employee	1,517,060.75x
Sector	Healthcare
Sic	2836
Symbol	bit/1GILD
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.77%
EV Earnings	18.53x
EV/EBIT	14.55x
EV/EBITDA	11.7x
EV/FCF	16.69x
EV/Sales	5.86x
FCF yield	6.4%
P/B ratio	6.82x
P/E ratio	17.33x
P/S ratio	5.37x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	34.4%
Gross margin	79.37%
Gross Profit	EUR 20.5B
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	EUR 8B
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	EUR 470,179
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	30.72%
Cagr3y	19.43%
Cagr5y	19.34%
Div CAGR3	-0.31%
Div CAGR5	3.34%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 48.8B
Cash	EUR 8.5B
Current Assets	EUR 15.8B
Current Liabilities	EUR 8B
Debt	EUR 19.2B
Debt EBITDA	EUR 1.49
Debt Equity	EUR 0.95
Debt FCF	EUR 2.17
Equity	EUR 20.3B
Interest Coverage	11.94
Liabilities	EUR 28.5B
Long Term Assets	EUR 33B
Long Term Liabilities	EUR 20.5B
Net Cash	EUR -9.9B
Net Cash By Market Cap	EUR -7.12
Net Debt EBITDA	EUR 0.77
Net Debt Equity	EUR 0.49
Net Debt FCF	EUR 1.11
Tangible Book Value	EUR -1B
Tangible Book Value Per Share	EUR -0.82
WACC	5.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	EUR 573.3M
Quick ratio	1.54
Working Capital	EUR 7.9B
Working Capital Turnover	EUR 3.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	-3.19%
Dividend Growth Years	0%
Dividend per share	EUR 2.03
Dividend Years	9
Dividend Yield	1.82%
Ex Div Date	2025-12-12
Last Dividend	EUR 0.67
Payout Ratio	31.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	30.69%
200-day SMA	108.9
3Y total return	70.38%
50-day SMA	119.2
50-day SMA vs 200-day SMA	50over200
5Y total return	142.05%
All Time High	132.7
All Time High Change	-15.99%
All Time High Date	2026-03-12
All Time Low	40.41
All Time Low Change	175.89%
All Time Low Date	2018-05-08
ATR	1.67
Beta	0.33
Ch YTD	6.05
High	113.7
High52	132.7
High52 Date	2026-03-12
High52ch	-15.99%
Low	109.4
Low52	82.79
Low52 Date	2025-05-12
Low52ch	34.65%
Ma50ch	-6.49%
Price vs 200-day SMA	2.4%
RSI	39.58
RSI Monthly	60.47
RSI Weekly	47.68
Sharpe ratio	0.9x
Sortino ratio	1.59
Total Return	2.11%
Tr YTD	6.05
Tr1m	-6.68%
Tr1w	-0.87%
Tr3m	-13.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 10.4B
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,252,307%
Net Borrowing	-2,367,509,904
Shares Insiders	0.1%
Shares Institutions	89.54%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 8.1B
Average Volume	87.95x
Bv Per Share	16.42
CAPEX	EUR -499.6M
Ch1m	-6.68
Ch1w	-0.87
Ch1y	28.05
Ch3m	-13.12
Ch3y	54.75
Ch5y	102.1
Ch6m	7.07
Change	-2.96%
Change From Open	-1.94
Close	114.9
Days Gap	-1.04
Depreciation Amortization	2,334,439,386
Dollar Volume	68,114.3
Earnings Date	2026-05-07
EBIT	EUR 10.4B
EBITDA	EUR 12.8B
EPS	EUR 6.38
F Score	8
FCF	EUR 8.9B
FCF EV Yield	5.99x
Financing CF	-7,422,353,400
Fiscal Year End	December
Founded	1,987
Goodwill	7,049,956,068
Graham Number	48.64908
Graham Upside	-56.36
Income Tax	EUR 1.3B
Investing CF	-2,261,918,400
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 161
Lynch Upside	44.25
Ma150	112.5
Ma150ch	-0.93%
Ma20	114.3
Ma20ch	-2.45%
Net CF	-257,588,100
Next Earnings Date	2026-08-06
Open	113.7
P FCF Ratio	15.61
P OCF Ratio	14.78
Payment Date	2025-12-30
Position In Range	48.36
Ppne	4,780,809,756
Price Date	2026-05-08
Price EBITDA	EUR 10.84
Relative Volume	6.95x
Revenue	25,790,032,800x
SBC By Revenue	3.04x
Share Based Comp	783,171,900
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	7.76%
Volume	611
Z Score	4.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BIT/1GILD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$2.03 annual per share

Payout ratio

+31.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.3%

0 consecutive years of growth

Total shareholder yield

+2.2%

Next ex-dividend date: 2025-12-12

Performance

BIT/1GILD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/1GILD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+89.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIT/1GILD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.6

Neutral momentum band

Price vs 200-day MA

+2.4%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/1GILD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1GILD stock rating?

bit/1GILD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1GILD analysis?

The full report lives at /stocks/bit/1GILD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1GILD?

The latest report frames bit/1GILD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1GILD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.